Citable company snapshot
Lilly (Eli)'s latest SEC-sourced 2026-06-30 period shows $22.97B in revenue and $7.09B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| Revenue | Jun 30, 2026 | $22.97B | $19.80B | +16.0% |
| Net Income | Jun 30, 2026 | $7.09B | $7.40B | -4.1% |
| Operating Cash Flow (computed) | Jun 30, 2026 | $10.69B | $5.33B | +100.5% |
| Free Cash Flow (computed) | Sep 30, 2022 | $1.60B | $812.30M | +96.9% |
Source: SEC EDGAR financial statements; period Jun 30, 2026; filed Aug 5, 2026; accession 0000059478-26-000081.
LLY company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.
Continue research
Follow same-sector companies and source explainers connected to the overview view.
A factual guide to market capitalization, shares outstanding, public float, and why share-count definitions matter.
A factual guide to dividends, share repurchases, and how companies can return capital to shareholders.
A factual guide to book value, tangible book value, and balance-sheet net worth measures.
A factual guide to the core 10-K sections investors use for company context: business description, risk factors, MD&A, financial statements, and segment disclosures.